Musaddiq Awan, James Caudell, Stuart Wong, Baran Sumer, Kedar Kirtane, Joseph Zenga, David Sher. "Notably Off Key: Questioning the Clinical Benefit of Perioperative Immunotherapy for Resectable Head and Neck Squamous Cell Carcinoma After KEYNOTE-689." Journal of Clinical Oncology, 2026. doi:10.1200/jco-25-01990